Sleep Science — 2026-10-10
This week's sleep science updates focus on the expanding clinical evidence for insomnia treatments and emerging trends in botanical sleep aids. Key developments include the presentation of pediatric data for daridorexant at Sleep Europe 2026 and a shift toward targeting stress pathways in sleep health formulations.
Sleep Science — 2026-10-10
Key Highlights
Pediatric Insomnia Data Presented at Sleep Europe 2026 New Phase 2 results regarding the use of daridorexant, a dual orexin receptor antagonist (DORA), in children with insomnia disorder were presented as a late-breaking "Impactful Clinical Trial" session. These represent the first investigational data of this drug class in pediatric populations, alongside growing real-world evidence for adult insomnia management.
Botanicals Target Stress Pathways for Sleep Health Formulators are increasingly moving away from simple sedatives toward botanicals such as ashwagandha, bacopa, saffron, and PEA. These ingredients are being utilized to target the underlying stress, cortisol, and nervous-system pathways that contribute to restless nights, rather than just masking symptoms.
Analysis
The most significant development this cycle is the expansion of DORA therapy into the pediatric space. While dual orexin receptor antagonists have become a standard treatment option for adults with chronic insomnia, their application in children has remained largely unexplored until now. The presentation of Phase 2 data at Sleep Europe 2026 marks a critical step in establishing whether the mechanism of action—blocking orexin receptors to prevent wakefulness—is safe and effective for developing brains. This aligns with broader industry trends noted by the American Academy of Sleep Medicine, which continues to highlight innovations in sleep medicine through its quarterly reports.
Sleep Hack
Target Cortisol Before Bed Instead of reaching for standard melatonin or sedatives, consider incorporating adaptogenic botanicals like ashwagandha into your evening routine. Recent industry analysis suggests these compounds work by modulating the body's stress response and cortisol levels, addressing the root cause of hyperarousal that often prevents sleep onset.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
